AST/ESOT Joint Meeting
October 17 – 19, 2014
Long-term survival is the ongoing issue in transplantation. Outcomes are affected by individual immune risk, as well as gender and race. The time is now to focus on improving outcomes through personalized medicine and finding finding the optimal combination of drugs in the right dose for each patient.
Visit the ESOT website to register.